Epigenetic Targets in Drug Discovery
โ Scribed by Sippl W., Jung M.
- Publisher
- Wiley-VCH
- Year
- 2009
- Tongue
- English
- Leaves
- 310
- Series
- Methods and Principles in Medicinal Chemistry 42
- Category
- Library
No coin nor oath required. For personal study only.
โฆ Table of Contents
Cover......Page 1
Frontmatter......Page 2
Contents......Page 6
List of Contributors......Page 13
Preface......Page 16
A Personal Foreword......Page 19
Part One
General Aspects and Methodologies......Page 22
1 New Frontiers in Epigenetic Modifications......Page 23
2 Structural Biology of Epigenetic Targets......Page 43
3 Computer- and Structure-Based Lead Identification for Epigenetic Targets......Page 77
4 Histone Modification Analysis Using Mass Spectrometry......Page 106
5 In Vitro Assays for Histone-Modifying Enzymes......Page 117
6 Epigenetic Targets in Drug Discovery: Cell-Based Assays for HDAC Inhibitor Hit Validation......Page 137
7 Chromatin Immunoprecipitation ChIP: Wet Lab Meets In Silico......Page 156
Part Two
Epigenetic Target Classes and Inhibitor Development......Page 177
8 DNA Methyltransferase Inhibitors......Page 178
9 Histone Deacetylase Inhibitors......Page 199
10 NAD-Dependent Deacetylases as Therapeutic Targets......Page 238
11 Inhibitors of Histone Acetyltransferases: Discovery and Biomedical Perspectives......Page 256
12 Histone Methyltransferases as Novel Drug Targets......Page 264
13 Histone Demethylases......Page 282
Index......Page 304
๐ SIMILAR VOLUMES
Fueled by the expertise of a team of international specialist authors, this first reference on the booming topic covers everything a drug researcher needs to know about targeting epigenetic mechanisms of disease. <br> The first part of the book surveys current methodologies for finding and validatin
<p><i>Drug Discovery in Cancer Epigenetics</i> is a practical resource for scientists involved in the discovery, testing, and development of epigenetic cancer drugs. Epigenetic modifications can have significant implications for translational science as biomarkers for diagnosis, prognosis or therapy